2006
Cambridge Research Institute
David Tuveson, M.D., Ph.D.
Novel Anti-K-ras Strategies in Ductal Pancreatic Cancer
Georgetown University Medical Center
Anna Riegel, Ph.D.
The Role of the Nuclear Receptor Coactivator AIB1in the Early Preneoplastic Stages of Pancreatic Cancer
Johns Hopkins Medical Institutions
Marcia Canto, M.D.
Screening for Early Pancreatic Neoplasia: A Multi-Center Study
Johns Hopkins Medical Institutions
Elizabeth Jaffee, M.D.
Functional Genomic Approach to Identify Genes that are Pancreatic Cancer Immune Targets
Johns Hopkins Medical Institutions
Steven D. Leach, M.D.
High-Throughput, In-Vivo Screening for Novel Pancreatic Cancer Drugs Using the Zebrafish System
Johns Hopkins Medical Institutions
Joshua Mendell, M.D., Ph.D.
The Role of MicroRNAs in the Pathogenesis of Pancreatic Cancer
Technical University of Munich
Roland Schmid, M.D.
Jens T. Svieke, M.D.
The Role of Notch Signaling in Pancreatic Cancer Development
University of Michigan Medical Center
Diane Simeone, M.D.
Pancreatic Cancer Stem Cells
University of Texas M.D. Anderson Cancer Center
George Halder, Ph.D.
A Novel Genetic System to Identify Ideal Cancer Drug Targets in Pancreatic Cancer
University of Utah
Lewis Charles Murtaugh, Ph.D.
Interdependence of Notch and Kras Signaling in Pancreatic Tumorigenesis